cDNA

Ebola Virus Illness Survivors Present Extra Environment friendly Antibody Immunity than Vaccinees Regardless of Comparable Ranges of Circulating Immunoglobulins

The final seven years have seen the best surge of Ebola virus illness (EVD) circumstances in equatorial Africa, together with the 2013-2016 epidemic in West Africa and the latest epidemics within the Democratic Republic of Congo (DRC). The vaccine scientific trials that befell in West Africa and the DRC, in addition to follow-up research in collaboration with EVD survivor communities, have for the primary time allowed researchers to check immune reminiscence induced by pure an infection and vaccination.
These comparisons could also be related to guage the putative effectiveness of vaccines and candidate medical countermeasures corresponding to convalescent plasma switch.
On this research, we in contrast the long-term performance of anti-EBOV glycoprotein (GP) antibodies from EVD survivors with that from volunteers who obtained the recombinant vesicular stomatitis virus vectored vaccine (rVSV-ZEBOV) throughout the Section I scientific trial in Hamburg.
Our research highlights necessary variations between EBOV vaccination and pure an infection and offers a framework for comparability with different vaccine candidates.
cDNA

cDNA

Anti-Mouse IL-1 R2 Antibody

103-M138 100 µg
EUR 399
Description: IL-1 receptor type II (IL1R-II) is a 65 kD member of the immunoglobulin superfamily also known as IL-1 receptor (IL1R) type II. The IL1R family is composed of three proteins: IL1R type I, IL1-RII, and the widely expressed IL-1RAcP.

IL-1 R2 (Human) LumiAb ELISA Kit

MBS9510883-10x96StripWells 10x96-Strip-Wells
EUR 4355

IL-1 R2 (Human) LumiAb ELISA Kit

MBS9510883-5x96StripWells 5x96-Strip-Wells
EUR 2225

IL-1 R2 (Human) LumiAb ELISA Kit

MBS9510883-96StripWells 96-Strip-Wells
EUR 500

IL-1 R2 (Human) OmniKine ELISA Kit

MBS9501955-1x96Wells 1x96Wells
EUR 500

IL-1 R2 (Human) OmniKine ELISA Kit

MBS9501955-5x96Wells 5x96Wells
EUR 2300

IL-1 R2 (Human) Sandwich ELISA Kit

OK-0229 1Kit
EUR 280
Description: IL-1 R2 (Human) Colorimetric Sandwich ELISA Kit

IL-1 R2 ELISA Kit (Human) : 96 Wells (OKAG00129)

OKAG00129 96 Wells
EUR 715.2
Description: Description of target: The protein encoded by this gene is a cytokine receptor that belongs to the interleukin 1 receptor family. This protein binds interleukin alpha (IL1A), interleukin beta (IL1B), and interleukin 1 receptor, type I(IL1R1/IL1RA), and acts as a decoy receptor that inhibits the activity of its ligands. Interleukin 4 (IL4) is reported to antagonize the activity of interleukin 1 by inducing the expression and release of this cytokine. This gene and three other genes form a cytokine receptor gene cluster on chromosome 2q12. Alternative splicing results in multiple transcript variants and protein isoforms. Alternative splicing produces both membrane-bound and soluble proteins. A soluble protein is also produced by proteolytic cleavage.;Species reactivity: Human;Application: ELISA;Assay info: Quantitative Colorimentric Sandwich ELISA;Sensitivity: 32 pg/mL

IL 1 R2 Recombinant Protein

96-436 0.1 mg
EUR 619.8
Description: Interleukin-1 receptor type 2 (IL1R2) is also known as CD121 antigen-like family member B (CDw121b), IL-1 type II receptor, Interleukin-1 receptor type II, belongs to the interleukin-1 receptor family. Two distinct types of IL1 receptors which are able to bind IL1 specifically have been identified, designated as IL1RI (IL1RA) and IL1RII (IL1RB). IL1R2 is non-signaling receptor for IL1A, IL1B and IL1RN, reduces IL1B activities. Serves as a decoy receptor by competetive binding to IL1B and preventing its binding to IL1R1. IL1R2 modulates cellular response through non-signaling association with IL1RAP after binding to IL1B. IL1R2 (membrane and secreted forms) preferentially binds IL1B and poorly IL1A and IL1RN. The secreted IL1R2 recruits secreted IL1RAP with high affinity; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors.

Mouse Anti Human IL-1 beta

MBS140161-05mg 0.5mg
EUR 440

Mouse Anti Human IL-1 beta

MBS140161-1mg 1mg
EUR 600

Mouse Anti Human IL-1 beta

MBS140161-5x1mg 5x1mg
EUR 2375

Recombinant Mouse IL-1 R2/IL-1 RII Protein

RP00726 10μg
EUR 136.5
  • Mouse Interleukin 1 receptor, type II (IL1R2) is a cytokine receptor that belongs to the interleukin-1 receptorfamily. This protein binds interleukin alpha (IL1A), interleukin beta (IL1B), and interleukin 1 receptor, type I(IL1R1/IL1RA), and acts as
  • Show more

Recombinant Mouse IL-1 R2/IL-1 RII Protein

RP00729 10μg
EUR 138.16

Anti‐Human IL‐17A

E2790213 100ul
EUR 225
Description: Available in various conjugation types.

Mouse Anti Human IL-1 beta FITC

MBS140163-05mg 0.5mg
EUR 440

Mouse Anti Human IL-1 beta FITC

MBS140163-1mg 1mg
EUR 600

Mouse Anti Human IL-1 beta FITC

MBS140163-5x1mg 5x1mg
EUR 2375

human anti-human IL-1 β mAb(14)

E4A09D02-14 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human IL-1 β mAb(7Z)

E4A09D02-7Z 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Monoclonal Mouse anti Human IL-1 beta

MBS550073-05mg 0.5mg
EUR 595

Monoclonal Mouse anti Human IL-1 beta

MBS550073-1mg 1mg
EUR 915

Mouse Anti Human IL-1 beta Biotinylated

MBS140162-05mg 0.5mg
EUR 440

Mouse Anti Human IL-1 beta Biotinylated

MBS140162-1mg 1mg
EUR 600

Mouse Anti Human IL-1 beta Biotinylated

MBS140162-5x1mg 5x1mg
EUR 2375

TNF-R2 (human)

TN-004 50 µg
EUR 738

anti-PKA R2

YF-PA13990 50 ul
EUR 435.6
Description: Mouse polyclonal to PKA R2

anti-PKA R2

YF-PA24454 50 ul
EUR 400.8
Description: Mouse polyclonal to PKA R2

human anti-human IL-2 mAb

E409C12-h100 100μL
EUR 395
Description: Available in various conjugation types.

human anti-human IL-4 mAb

E409C13-h100 100μL
EUR 395
Description: Available in various conjugation types.

human anti-human IL-5 mAb

E409C14-h100 100μL
EUR 395
Description: Available in various conjugation types.

human anti-human IL-8 mAb

E409C16-h100 100μL
EUR 395
Description: Available in various conjugation types.

human anti-human IL-5 mAb

E4A09D05 50ug
EUR 255
Description: Available in various conjugation types.

Human anti-Human IL-2 mAb

MBS8576800-005mg 0.05mg
EUR 325

Human anti-Human IL-2 mAb

MBS8576800-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-2 mAb

MBS8576800-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-2 mAb

MBS8576800-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-2 mAb

MBS8576800-01mLAF635 0.1mL(AF635)
EUR 565

Human anti-Human IL-4 mAb

MBS8576802-005mg 0.05mg
EUR 325

Human anti-Human IL-4 mAb

MBS8576802-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-4 mAb

MBS8576802-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-4 mAb

MBS8576802-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-4 mAb

MBS8576802-01mLAF635 0.1mL(AF635)
EUR 565

Human anti-Human IL-5 mAb

MBS8576804-005mg 0.05mg
EUR 325

Human anti-Human IL-5 mAb

MBS8576804-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-5 mAb

MBS8576804-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-5 mAb

MBS8576804-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-5 mAb

MBS8576804-01mLAF635 0.1mL(AF635)
EUR 565

Human anti-Human IL-8 mAb

MBS8576808-005mg 0.05mg
EUR 325

Human anti-Human IL-8 mAb

MBS8576808-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-8 mAb

MBS8576808-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-8 mAb

MBS8576808-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-8 mAb

MBS8576808-01mLAF635 0.1mL(AF635)
EUR 565

human anti-human IL-1β mAb

E409C11-h100 100μL
EUR 395
Description: Available in various conjugation types.

human anti-human IL-10 mAb

E409C17-h100 100μL
EUR 395
Description: Available in various conjugation types.

Human anti-Human IL-10 mAb

MBS8576810-005mg 0.05mg
EUR 325

Human anti-Human IL-10 mAb

MBS8576810-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-10 mAb

MBS8576810-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-10 mAb

MBS8576810-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-10 mAb

MBS8576810-01mLAF635 0.1mL(AF635)
EUR 565

Human anti-Human IL-1beta mAb

MBS8576798-005mg 0.05mg
EUR 325

Human anti-Human IL-1beta mAb

MBS8576798-01mLAF405L 0.1mL(AF405L)
EUR 565

Human anti-Human IL-1beta mAb

MBS8576798-01mLAF405S 0.1mL(AF405S)
EUR 565

Human anti-Human IL-1beta mAb

MBS8576798-01mLAF610 0.1mL(AF610)
EUR 565

Human anti-Human IL-1beta mAb

MBS8576798-01mLAF635 0.1mL(AF635)
EUR 565

human anti-human IL-12/IL-23 p40 mAb(3H2)

E4A09D33-3H2 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human IL-12/IL-23 p40 mAb(5N9)

E4A09D33-5N9 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human IL-12/IL-23 p40 mAb(1G11)

E4A09D33-1G11 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Anti-Human TGF beta R2 Antibody

101-M178 100 µg
EUR 399
Description: Most cell types express three sizes of receptors for TGF-beta. These are designated Type I (53 kDa), Type II (70 - 85 kDa), and Type III (250 - 350 kDa). The Type I receptor is a membrane-bound serine/threonine kinase that apparently requires the presence of the Type II receptor to bind TGF-beta. The Type II receptor is also a membrane-bound serine/threonine kinase that binds TGF-beta1 and TGF-beta 3 with high affinity and TGF-beta 2 with much lower affinity. The Type I and Type II receptors together form a heterodimeric signaling complex that is essential for the transduction of the anti-proliferative signals of TGF-beta. The Type III receptor is a transmembrane proteoglycan with a large extracellular domain and a 43 amino acid residue cytoplasmic domain. The cytoplasmic domain of the Type III receptor lacks an obvious signaling motif and the receptor may not be involved directly in signal transduction.

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543245-006mL 0.06mL
EUR 250

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543245-012mL 0.12mL
EUR 370

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543245-02mL 0.2mL
EUR 550

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543246-006mL 0.06mL
EUR 250

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543246-012mL 0.12mL
EUR 370

Mouse anti Human IL-1RAcP/IL-1R3 Monoclonal Antibody

MBS2543246-02mL 0.2mL
EUR 550

ApoE R2, Recombinant Human

MBS636329-005mg 0.05mg
EUR 880

ApoE R2, Recombinant Human

MBS636329-5x005mg 5x0.05mg
EUR 3730

MOUSE ANTI HUMAN CD126 (IL-6R)

MBS213171-01mg 0.1mg
EUR 355

MOUSE ANTI HUMAN CD126 (IL-6R)

MBS213171-5x01mg 5x0.1mg
EUR 1425

Mouse Monoclonal anti-human FGF-R2

hAP-0278 100ug
EUR 250

Mouse Monoclonal anti-human FGF-R2

hAP-0278A 100ug
EUR 250

Mouse Monoclonal anti-human Orexin R2

hAP-0850 50ug
EUR 400

human anti-human IL-2 mAb (D1)

E4A09D03-A7C 50ug
EUR 255
Description: Available in various conjugation types.

human anti-human IL-2 mAb (F5)

E4A09D03-B1F 50ug
EUR 255
Description: Available in various conjugation types.

Mechanism of Antibodies Purification by Protein A

Protein A, a serious cell wall part of Staphylococcus aureus, is likely one of the first immunoglobulin-binding proteins that’s found about 80 years in the past. Nonetheless, an excessive amount of improvement in each purification strategies and software of antibodies in therapy have been executed.
There are numerous publications primarily based on the untargeted (dimension exclusion, ion alternate and hydrophobic interactions) and focused (affinity) strategies by scientists in tutorial/trade teams. On this evaluate, now we have centered on the research of each native and engineered Protein A to grasp its mechanism within the purification of antibodies.
What area of Protein A dose work together with antibody? The place are contact areas? What’s the non-covalent interplay mechanism of Protein A and antibody? Does alkaline situation, within the washing step, affect on antibody construction and exercise? Then again, the immobilization of Protein A on numerous sorbents corresponding to agarose, silica, polysaccharide, polymers, and magnetic nanoparticles have investigated.
Additionally, the appliance of Protein A as biosensor for detection of the antibody is mentioned. We’ve got tried to seek out fascinating and stimulating solutions to all these questions.

Selective elimination of human pluripotent stem cells by Anti-Dsg2 antibody-doxorubicin conjugates

The self-renewal properties of human pluripotent stem cells (hPSCs) contribute to their efficacy in tissue regeneration purposes but improve the probability of teratoma formation, thereby limiting their scientific utility. To deal with this difficulty, we developed a device to particularly goal and neutralize undifferentiated hPSCs, thereby minimizing tumorigenicity danger with out negatively affecting regenerated and somatic tissues.
Particularly, we conjugated a monoclonal antibody (K6-1) beforehand generated in our laboratory in opposition to desmoglein 2 (Dsg2), which is extremely differentially expressed in undifferentiated hPSCs versus somatic tissues, to the chemotherapeutic agent doxorubicin (DOX).
The K6-1-DOX conjugates had been selectively focused and included into Dsg2-positive hPSCs, resulting in pH-dependent endosomal launch and nuclear localization of DOX with subsequent cytotoxicity by way of an apoptotic caspase cascade. Conversely, Dsg2-negative fibroblasts confirmed minimal conjugate uptake or cytotoxicity, suggesting that K6-1-DOX therapy would yield few unintended effects owing to off-target results.
Selective elimination of undifferentiated stem cells was additionally supported by in vivo research utilizing a mouse xenograft mannequin, whereby hIgG-DOX- however not K6-1-DOX-pretreated-hPSC injection led to teratoma improvement. Collectively, these outcomes validated the flexibility of the Dsg2-targeted antibody-anticancer drug conjugate to facilitate the security of stem cell therapies.

Antibody Conjugation of Nanoparticles as Therapeutics for Breast Most cancers Remedy

Breast most cancers is the most typical invasive tumor in girls and the second main reason behind cancer-related loss of life. Nanomedicine raises excessive expectations for hundreds of thousands of sufferers as it might probably present higher, extra environment friendly, and reasonably priced healthcare, and it has the potential to develop novel therapeutics for the therapy of strong tumors.
On this regard, focused therapies will be encapsulated into nanocarriers, and these nanovehicles are guided to the tumors via conjugation with antibodies-the so-called antibody-conjugated nanoparticles (ACNPs). ACNPs can protect the chemical construction of medicine, ship them in a managed method, and cut back toxicity.
As sure breast most cancers subtypes and indications have restricted therapeutic choices, this discipline offers hope for the long run therapy of sufferers with troublesome to deal with breast cancers. On this evaluate, we talk about the appliance of ACNPs for the therapy of this illness. Given the truth that ACNPs have proven scientific exercise on this scientific setting, particular emphasis on the function of the nanovehicles and their translation to the clinic is positioned on the revision.

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (APC)

MBS6269705-01mL 0.1mL
EUR 890

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (APC)

MBS6269705-5x01mL 5x0.1mL
EUR 3865

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (HRP)

MBS6269708-01mL 0.1mL
EUR 890

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (HRP)

MBS6269708-5x01mL 5x0.1mL
EUR 3865

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (PE)

MBS6269714-01mL 0.1mL
EUR 890

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (PE)

MBS6269714-5x01mL 5x0.1mL
EUR 3865

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (FITC)

MBS6269707-01mL 0.1mL
EUR 890

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (FITC)

MBS6269707-5x01mL 5x0.1mL
EUR 3865

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (Biotin)

MBS6269706-01mL 0.1mL
EUR 890

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (Biotin)

MBS6269706-5x01mL 5x0.1mL
EUR 3865

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (MaxLight 405)

MBS6269709-01mL 0.1mL
EUR 890

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (MaxLight 405)

MBS6269709-5x01mL 5x0.1mL
EUR 3865

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (MaxLight 490)

MBS6269710-01mL 0.1mL
EUR 890

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (MaxLight 490)

MBS6269710-5x01mL 5x0.1mL
EUR 3865

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (MaxLight 550)

MBS6269711-01mL 0.1mL
EUR 890

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (MaxLight 550)

MBS6269711-5x01mL 5x0.1mL
EUR 3865

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (MaxLight 650)

MBS6269712-01mL 0.1mL
EUR 890

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (MaxLight 650)

MBS6269712-5x01mL 5x0.1mL
EUR 3865

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (MaxLight 750)

MBS6269713-01mL 0.1mL
EUR 890

JAM-C (Junctional Adhesion Molecule C, JAM-2, Junctional Adhesion Molecule 3, JAM-3) (MaxLight 750)

MBS6269713-5x01mL 5x0.1mL
EUR 3865

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (AP)

MBS6456767-02mL 0.2mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (AP)

MBS6456767-5x02mL 5x0.2mL
EUR 4250

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (APC)

MBS6456768-02mL 0.2mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (APC)

MBS6456768-5x02mL 5x0.2mL
EUR 4250

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (HRP)

MBS6456771-02mL 0.2mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (HRP)

MBS6456771-5x02mL 5x0.2mL
EUR 4250

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (PE)

MBS6456777-02mL 0.2mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (PE)

MBS6456777-5x02mL 5x0.2mL
EUR 4250

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (FITC)

MBS6456770-02mL 0.2mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (FITC)

MBS6456770-5x02mL 5x0.2mL
EUR 4250

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (Biotin)

MBS6456769-02mL 0.2mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (Biotin)

MBS6456769-5x02mL 5x0.2mL
EUR 4250

Human Junctional adhesion molecule B (JAM2)

1-CSB-YP011936HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
  • MW: 25.5 kDa
  • Buffer composition: Tris-based buffer with 50% glycerol.
Description: Recombinant Human Junctional adhesion molecule B(JAM2),partial expressed in Yeast

Human Junctional adhesion molecule B (JAM2)

1-CSB-EP011936HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
  • MW: 27.5 kDa
  • Buffer composition: Tris-based buffer with 50% glycerol.
Description: Recombinant Human Junctional adhesion molecule B(JAM2),partial expressed in E.coli

Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-Fc)

AP75554 1mg
EUR 3209
  • Human Cells

Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-Fc)

CC52-10ug 10ug
EUR 175.2
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4 .

Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-Fc)

CC52-1mg 1mg
EUR 2739.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4 .

Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-Fc)

CC52-500ug 500ug
EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4 .

Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-Fc)

CC52-50ug 50ug
EUR 363.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4 .

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (MaxLight 405)

MBS6456772-01mL 0.1mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (MaxLight 405)

MBS6456772-5x01mL 5x0.1mL
EUR 4250

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (MaxLight 490)

MBS6456773-01mL 0.1mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (MaxLight 490)

MBS6456773-5x01mL 5x0.1mL
EUR 4250

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (MaxLight 550)

MBS6456774-01mL 0.1mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (MaxLight 550)

MBS6456774-5x01mL 5x0.1mL
EUR 4250

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (MaxLight 650)

MBS6456775-01mL 0.1mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (MaxLight 650)

MBS6456775-5x01mL 5x0.1mL
EUR 4250

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (MaxLight 750)

MBS6456776-01mL 0.1mL
EUR 980

JAM3 (Junctional Adhesion Molecule C, JAM-C, JAM-2, Junctional Adhesion Molecule 3, JAM-3, JAM3) (MaxLight 750)

MBS6456776-5x01mL 5x0.1mL
EUR 4250

Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-6His)

AP75079 1mg
EUR 3209
  • Human Cells

Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-6His)

C359-10ug 10ug
EUR 145.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2.

Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-6His)

C359-1mg 1mg
EUR 2739.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2.

Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-6His)

C359-500ug 500ug
EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2.

Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-6His)

C359-50ug 50ug
EUR 315.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2.

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245)

MBS6004595-005mg 0.05(mg
EUR 820

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245)

MBS6004595-5x005mg 5x0.05mg
EUR 3535

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245)

MBS6005117-01mg 0.1(mg
EUR 665

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245)

MBS6005117-5x01mg 5x0.1mg
EUR 2850

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245)

MBS6002216-01mg 0.1(mg
EUR 570

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245)

MBS6002216-5x01mg 5x0.1mg
EUR 2410

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245)

MBS648899-01mg 0.1mg
EUR 520

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245)

MBS648899-5x01mg 5x0.1mg
EUR 2185

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245)

MBS643566-01mg 0.1mg
EUR 630

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245)

MBS643566-5x01mg 5x0.1mg
EUR 2680

Human Junctional Adhesion Molecule 2/JAM-B Antibody (Biotin Conjugate)

33424-05121 150 ug
EUR 315

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) APC

MBS6137239-01mL 0.1(mL
EUR 875

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) APC

MBS6137239-5x01mL 5x0.1mL
EUR 3800

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (Biotin)

MBS6142542-01mL 0.1(mL
EUR 875

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (Biotin)

MBS6142542-5x01mL 5x0.1mL
EUR 3800

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (AP)

MBS6131936-01mL 0.1(mL
EUR 875

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (AP)

MBS6131936-5x01mL 5x0.1mL
EUR 3800

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (FITC)

MBS6147845-01mL 0.1(mL
EUR 875

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (FITC)

MBS6147845-5x01mL 5x0.1mL
EUR 3800

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (AP)

MBS6383355-01mL 0.1mL
EUR 920

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (AP)

MBS6383355-5x01mL 5x0.1mL
EUR 3990

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) APC

MBS6383356-01mL 0.1mL
EUR 920

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) APC

MBS6383356-5x01mL 5x0.1mL
EUR 3990

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (Biotin)

MBS6383357-01mL 0.1mL
EUR 920

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (Biotin)

MBS6383357-5x01mL 5x0.1mL
EUR 3990

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (FITC)

MBS6383358-01mL 0.1mL
EUR 920

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (FITC)

MBS6383358-5x01mL 5x0.1mL
EUR 3990

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (HRP)

MBS6383359-01mL 0.1mL
EUR 920

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (HRP)

MBS6383359-5x01mL 5x0.1mL
EUR 3990

JAM2 (Junctional Adhesion Molecule B, JAM-B, Junctional Adhesion Molecule 2, JAM-2, Vascular Endothelial Junction-associated Molecule, VE-JAM, CD322, C21orf43, VEJAM, UNQ219/PRO245) (PE)

MBS6383365-01mL 0.1mL
EUR 920